Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients

NCT02231580 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to subject recruitment problems.

Conditions

Interventions

Sponsor

Ipsen